First patent issued in Europe for Orexo's adrenaline product OX640 |
| September 01, 2022 | September 2022 Bond Updates |
|
UPPSALA, Sweden, Sept. 1, 2022 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the European Patent Office (EPO) has granted the first European patent specifically relating to OX640, Orexo's nasal adrenaline rescue medication based on the amorphOX® drug... |
| View more at: https://www.prnewswire.com:443/news-releases/first-patent-issued-in-europe-for-orexos-adrenaline-product-ox640-301616151.html |
| Related News |
|